Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eiger Biopharma
(NQ:
EIGR
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eiger Biopharma
< Previous
1
2
3
4
5
Next >
EIGER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm
December 23, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
December 18, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
EIGER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm
December 16, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
Eiger Shares Tumble Despite Phase 3 Study Meets Primary Endpoint
December 08, 2022
Via
Benzinga
Eiger BioPharmaceuticals's Return On Capital Employed Overview
November 24, 2022
Via
Benzinga
Eiger BioPharmaceuticals Announces Leadership Change
December 15, 2022
From
Eiger BioPharmaceuticals, Inc.
Via
Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
December 15, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SolarEdge, Eiger, Unisys, and Rent and Encourages Investors to Contact the Firm
December 12, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR
December 12, 2022
From
Rosen Law Firm
Via
Business Wire
ROSEN, A TOP RANKED LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
December 11, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
How Is The Market Feeling About Eiger BioPharmaceuticals?
December 09, 2022
Eiger BioPharmaceuticals's (NASDAQ:EIGR) short percent of float has fallen 8.23% since its last report. The company recently reported that it has 1.67 million shares sold short, which is 4.57% of all...
Via
Benzinga
S&P 500 Rises 0.5%; Ciena Posts Upbeat Q4 Results
December 08, 2022
U.S. stocks traded higher toward the end of trading, with the NASDAQ gaining around 100 points on Thursday.
Via
Benzinga
Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session
December 08, 2022
Gainers My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 08, 2022
Via
Benzinga
Nasdaq Gains 100 Points; Rent the Runway Shares Spike Higher
December 08, 2022
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Thursday.
Via
Benzinga
Eiger BioPharmaceuticals' Debt Overview
December 08, 2022
Shares of Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR) decreased by 85.08% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to...
Via
Benzinga
Dow Rises 150 Points; US Jobless Claims Increase To 230,000
December 08, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining over 150 points on Thursday.
Via
Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SolarEdge, Eiger, Unisys, and Rent the Runway and Encourages Investors to Contact the Firm
December 07, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 07, 2022
Via
Benzinga
ROSEN, A TOP RANKED LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
December 04, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
NASDAQ:EIGR Shareholder Notice: Lawsuit Alleges Misleading Statements by Eiger BioPharmaceuticals, Inc.
November 30, 2022
San Diego, CA -- (SBWIRE) -- 11/30/2022 -- An investor, who purchased shares of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR), filed a lawsuit against Eiger BioPharmaceuticals, Inc over alleged...
Via
SBWire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eiger BioPharmaceuticals, Inc. (EIGR)
November 28, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
ROSEN, A TOP RANKED LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
November 26, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
November 22, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Eiger BioPharmaceuticals, Inc. (EIGR) Investors
November 21, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
ROSEN, A TOP RANKED LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
November 20, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Eiger BioPharmaceuticals, Inc. (EIGR) Investors
November 18, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
November 17, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Eiger BioPharmaceuticals, Inc. (EIGR) Investors
November 17, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Eiger BioPharmaceuticals, Inc. (EIGR) on Behalf of Investors
November 16, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.